about
Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongationIdentification of evolutionarily conserved exons as regulated targets for the splicing activator tra2β in developmentRNA helicases DDX5 and DDX17 dynamically orchestrate transcription, miRNA, and splicing programs in cell differentiationAntagonistic factors control the unproductive splicing of SC35 terminal intron.Proteomic identification of heterogeneous nuclear ribonucleoprotein L as a novel component of SLM/Sam68 Nuclear Bodies.The germ cell nuclear proteins hnRNP G-T and RBMY activate a testis-specific exon.The centrosomal kinase NEK2 is a novel splicing factor kinase involved in cell survival.Identification of protein features encoded by alternative exons using Exon Ontology.The multiple functions of RNA helicases as drivers and regulators of gene expression.Recruitment of TFIIH to the HIV LTR is a rate-limiting step in the emergence of HIV from latencyHuman RBMY regulates germline-specific splicing events by modulating the function of the serine/arginine-rich proteins 9G8 and Tra2-{beta}.A conserved splicing mechanism of the LMNA gene controls premature aging.An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements.The RNA helicase DDX5 is a reprogramming roadblock.Complementarity of assembly-first and mapping-first approaches for alternative splicing annotation and differential analysis from RNAseq data.Functions of DEAD box RNA helicases DDX5 and DDX17 in chromatin organization and transcriptional regulationThe RNA helicase DDX17 controls the transcriptional activity of REST and the expression of proneural microRNAs in neuronal differentiationCharacterizing the interplay between gene nucleotide composition bias and splicingInterplay between coding and exonic splicing regulatory sequencesIntragenic recruitment of NF-κB drives splicing modifications upon activation by the oncogene Tax of HTLV-1
P50
Q24537588-EEE43234-861F-4E3E-8D55-F457D2F9A9F2Q28588811-03703566-592D-481F-A754-111D970F5738Q28910223-9F874FCC-BE31-4D06-BD66-212D62D46F80Q30493457-405176D2-DCF7-44CD-83D9-ADDD7CA99DA7Q30884876-DAEB38FC-EE28-40A7-9238-8B3BEFB88579Q33515248-4974CEF0-04EF-49EE-A2F6-431176BF414EQ37631845-C4B8CF7E-DB4A-4F3A-9D6A-F31325A49B07Q38434650-774C45BC-E5B9-49C5-BB23-227D08D17689Q38850747-FCE6F69A-E463-4CDF-B47C-990CB3DBA3EFQ42181127-4A464F4D-F5DC-4E8A-8559-C42A0A41FF74Q42831229-F359E2F8-9D53-4395-8751-CC43D58DE943Q45781073-38AE8E9B-B8B9-445F-B820-8722EC9D409BQ45855863-7AE55B17-9CFC-4B1A-9DFF-46A977E0870AQ46136259-78D29826-F260-43FB-8BDD-6CD7CB7B83EFQ52663596-565B5D4B-0295-485C-BCE4-EFE80EA31582Q57180536-C5B0F11A-8C57-4E93-8BDC-77D9556E9AB7Q57753086-41EF9754-BD80-46F2-A78D-779AD9491F15Q91554113-5414A6B1-3E18-4DDB-AB8C-C0E551922B86Q92952501-C4E6825E-F738-4DFA-BD80-0BB67BBA8612Q96431751-25ADA845-44BC-486B-9BEB-ACC1C96D8F44
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Cyril F Bourgeois
@ast
Cyril F Bourgeois
@en
Cyril F Bourgeois
@es
Cyril F Bourgeois
@nl
Cyril F Bourgeois
@sl
type
label
Cyril F Bourgeois
@ast
Cyril F Bourgeois
@en
Cyril F Bourgeois
@es
Cyril F Bourgeois
@nl
Cyril F Bourgeois
@sl
altLabel
Cyril F. Bourgeois
@en
prefLabel
Cyril F Bourgeois
@ast
Cyril F Bourgeois
@en
Cyril F Bourgeois
@es
Cyril F Bourgeois
@nl
Cyril F Bourgeois
@sl
P1053
E-6337-2010
P106
P21
P31
P3829
P496
0000-0002-0756-5501